Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors.
Adaptive Biotechnologies Corporation Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $15.23
-9.4% in 7d after detection
Post-detection moves
1h
—
1d
-5.0%
3d
+1.3%
7d
-9.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS